Wedrén H
Department of Urology and Andrology, University of Umeå, Sweden.
Scand J Urol Nephrol Suppl. 1989;123:1-36.
Patients with chronic prostatitis have an increased number of white blood cells in expressed prostatic secretion. Two groups can be separated, one is characterized by uropathogenic bacteria in expressed prostatic secretion and recurrent urinary tract infections, chronic bacterial prostatitis. In this group an immune response to the bacteria has been demonstrated. Patients belonging to the other group, non-bacterial prostatitis, have similar symptoms. Many harbour Gram-positive bacteria in a high number, often Staphylococcus epidermidis in expressed prostatic secretion. This bacteria is usually not considered in prostatitis in spite of extreme high numbers. The etiology of non-bacterial inflammations is thus unknown. Forty-three per cent of the patients with chronic prostatitis had Gram-positive bacteria and 13% had Gram-negative in expressed prostatic secretion. Forty-four per cent of patients referred with symptoms of prostatitis did not have any aerobic bacteria at the prostatic level in sufficient number for the diagnosis bacterial prostatitis according to Meares and Stamey and form thus a third group. Antibiotic treatment of patients with non-bacterial prostatitis reduced symptoms but also changed the bacterial flora in urethral and prostatic secretion in such a way that uropathogens were found after treatment. In a group of patients an immunologic response to Staph. epidermidis was searched for by measuring complement components (C3c, C4c) as well as ceruloplasmin in serum and immunoglobulins (IgA, IgG) in seminal plasma. A specific ELISA method to estimate antibodies in serum against Staph. epidermidis was tested. No specific pattern separated patients from controls or patients with Gram-negative bacteria from patients with Gram-positive bacteria. Staphylococcus saprophyticus in cultures from men with prostatitis were more frequent in the third quarter of the year. The bacteria seemed to appear during or after antibiotic treatment but disappeared spontaneously during a follow-up period of six months. Treatment with the surfactant sodium pentosanpolysulphate, a heparinoid, given orally to patients with chronic prostatitis reduced concomitant pain in muscles and joints. The possibility of an altered host factor function in the polymorphonuclear leucocytes of patients with chronic non-bacterial prostatitis colonized with Staph. epidermidis was investigated. Chemotaxis, phagocytosis and intracellular killing were reduced in vitro and may to a part explain the bacteriological findings. Careful evaluations must thus be performed of earlier neglected factors to reach better knowledge of the chronic prostatitis.
慢性前列腺炎患者的前列腺液中白细胞数量增多。可分为两组,一组的特征是前列腺液中有尿路致病性细菌且反复发生尿路感染,即慢性细菌性前列腺炎。在这组患者中已证实存在针对细菌的免疫反应。另一组患者为非细菌性前列腺炎,有类似症状。许多患者前列腺液中大量存在革兰氏阳性菌,通常是表皮葡萄球菌。尽管数量极高,但这种细菌在前列腺炎中通常未被考虑。因此,非细菌性炎症的病因尚不清楚。43%的慢性前列腺炎患者前列腺液中有革兰氏阳性菌,13%有革兰氏阴性菌。因前列腺炎症状前来就诊的患者中,44%在前列腺部位没有足够数量的需氧菌用于诊断细菌性前列腺炎(根据米尔斯和斯塔米的标准),因此构成第三组。对非细菌性前列腺炎患者进行抗生素治疗可减轻症状,但也会改变尿道和前列腺液中的细菌菌群,以至于治疗后发现了尿路病原体。在一组患者中,通过测量血清中的补体成分(C3c、C4c)以及铜蓝蛋白和精浆中的免疫球蛋白(IgA、IgG)来寻找对表皮葡萄球菌的免疫反应。测试了一种用于估计血清中抗表皮葡萄球菌抗体的特异性ELISA方法。没有特定模式能将患者与对照组区分开,也无法区分革兰氏阴性菌患者和革兰氏阳性菌患者。前列腺炎男性患者培养物中的腐生葡萄球菌在一年的第三季度更为常见。这种细菌似乎在抗生素治疗期间或之后出现,但在六个月的随访期内会自行消失。给慢性前列腺炎患者口服表面活性剂戊聚糖多硫酸酯(一种类肝素)可减轻肌肉和关节的伴随疼痛。研究了表皮葡萄球菌定植的慢性非细菌性前列腺炎患者多形核白细胞中宿主因子功能改变的可能性。体外实验中趋化性、吞噬作用和细胞内杀伤作用均降低,这可能部分解释了细菌学检查结果。因此,必须对早期被忽视的因素进行仔细评估,以更好地了解慢性前列腺炎。